Adjuvant radiotherapy in endometrial carcinoma

Area of Science:

• Gynecologic Oncology
• Radiation Oncology
• Evidence-Based Medicine

Background:

• Endometrial cancer is a common malignancy affecting numerous women annually.
• Controversy persists regarding adjuvant radiation therapy despite numerous prospective trials.
• Current management strategies vary based on risk stratification.

Purpose of the Study:

• To critically evaluate the evidence surrounding adjuvant radiation therapy in endometrial cancer.
• To address the controversies in managing early-stage, intermediate-risk, and high-risk endometrial cancer.
• To provide an evidence-based approach to adjuvant radiotherapy decisions.

Main Methods:

• Review of prospective randomized trials and relevant literature.
• Analysis of risk stratification in endometrial cancer management.
• Examination of patterns of failure and radiotherapy targets.

Main Results:

• Low-risk early-stage disease generally does not require adjuvant therapy.
• Radiotherapy effectively reduces local-regional relapse in intermediate-risk patients, with no significant survival impact.
• High-risk patients benefit from chemotherapy for distant failure and may benefit from targeted radiotherapy for local failure.

Conclusions:

• The use of adjuvant radiotherapy in intermediate-risk endometrial cancer lacks consensus due to unclear survival benefits.
• Differing recommendations exist for radiotherapy targets in intermediate-risk patients based on failure patterns.
• Adjuvant radiotherapy decisions should be individualized based on risk stratification and evidence.